Other OTC - Delayed Quote USD

Rapid Dose Therapeutics Corp. (RDTCF)

0.0029 -0.0122 (-80.79%)
At close: May 17 at 9:30 AM EDT
Loading Chart for RDTCF
DELL
  • Previous Close 0.0151
  • Open 0.0029
  • Bid --
  • Ask --
  • Day's Range 0.0029 - 0.0029
  • 52 Week Range 0.0021 - 0.2932
  • Volume 1,675
  • Avg. Volume 12,177
  • Market Cap (intraday) 18.113M
  • Beta (5Y Monthly) 0.64
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date Jul 26, 2024 - Jul 30, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance outcomes in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active molecule into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products. It also provides product innovation, production, and consultation services to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing industries. Rapid Dose Therapeutics Corp. is headquartered in Burlington, Canada.

rapid-dose.com

--

Full Time Employees

February 28

Fiscal Year Ends

Recent News: RDTCF

Performance Overview: RDTCF

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RDTCF
80.79%
S&P/TSX Composite index
7.19%

1-Year Return

RDTCF
97.43%
S&P/TSX Composite index
10.98%

3-Year Return

RDTCF
98.46%
S&P/TSX Composite index
16.00%

5-Year Return

RDTCF
99.49%
S&P/TSX Composite index
34.57%

Compare To: RDTCF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RDTCF

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    18.14M

  • Enterprise Value

    20.04M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.39

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    26.08

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -80.78%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.05M

  • Net Income Avi to Common (ttm)

    -3.56M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    166.18k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    86.13k

Research Analysis: RDTCF

Company Insights: RDTCF

Research Reports: RDTCF

People Also Watch